Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-10-17Clinical Trial Update: Safety, Biodistribution, Radiation Dosimetry and Pharmacokinetics Study of BAY88-8223 in Japanese Patients [Phase 1]
Phase 1 study assessing safety, biodistribution, radiation dosimetry, and pharmacokinetics of BAY88-8223 in Japanese patients with prostate …
-
CLINICAL_TRIALS research · 2016-10-17Clinical Trial Update: Carbon Ion Radiotherapy in Treating Patients Undergoing Systemic Therapy for Oligo-metastatic Prostate Cancer [Phase 2]
A Phase 2 clinical trial update assessing carbon ion radiotherapy for patients with oligometastatic prostate cancer who are receiving system…
-
CLINICAL_TRIALS trial_result · 2016-10-14Clinical Trial Update: Comparison of Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With OGX-011 in Men With Prostate Cancer [Phase 3]
A Phase 3 trial evaluating OGX-011 in combination with docetaxel and prednisone for men with prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-14Clinical Trial Update: Comparing 0.5 mg Dutasteride vs Placebo Daily in Men Receiving Androgen Ablation Therapy for Prostate Cancer [Phase 2, Phase 3]
A Phase 2/3 trial comparing 0.5 mg daily dutasteride to placebo in men receiving androgen deprivation therapy for prostate cancer has comple…
-
CLINICAL_TRIALS research · 2016-10-14Clinical Trial Update: Active Surveillance Magnetic Resonance Imaging Study [Phase 3]
A Phase 3 study evaluating active surveillance MRI for prostate cancer is being conducted by the Canadian Urology Research Consortium. The c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-10-14Clinical Trial Update: A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate Cancer [Phase 4]
Phase 4 open-label crossover study in men with advanced prostate cancer evaluating whether switching among Lupron, Eligard, and Zoladex main…
-
CLINICAL_TRIALS withdrawal · 2016-10-14Clinical Trial Update: Radium 223 Following Intermittent ADT [Phase 2]
A Phase 2 trial evaluating Radium-223 following intermittent androgen deprivation therapy for prostate cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-10-14Clinical Trial Update: Safety Study of Human MUC-1 (Mucin-1) Adenoviral Vector Vaccine for Immunotherapy of Epithelial Cancers [Phase 1]
This entry covers a Phase 1 safety study of a human MUC-1 adenoviral vector vaccine designed for immunotherapy of epithelial cancers. The st…
-
CLINICAL_TRIALS trial_result · 2016-10-12Clinical Trial Update: Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate Cancer [Phase 3]
Phase 3 trial in second-line prostate cancer comparing cabazitaxel/prednisone alone to with custirsen has completed. The document does not i…
-
CLINICAL_TRIALS trial_result · 2016-10-11Clinical Trial Update: Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate Cancer [Phase 3]
A Phase 3 trial compares cabazitaxel at 20 mg/m² vs 25 mg/m² with prednisone in metastatic castration-resistant prostate cancer; results hav…
-
CLINICAL_TRIALS trial_result · 2016-10-11Clinical Trial Update: Whole Body Bone Scan vs 18F-Choline PET/CT in Prostate Cancer [NA]
The trial comparing whole-body bone scan versus 18F-choline PET/CT in prostate cancer has completed.
-
CLINICAL_TRIALS research · 2016-10-07Clinical Trial Update: S9346A Blood Samples From Patients With Metastatic Prostate Cancer Previously Treated With Bicalutamide and Goserelin
This clinical trial update describes S9346A blood samples collected from metastatic prostate cancer patients who were previously treated wit…
-
CLINICAL_TRIALS trial_result · 2016-10-06Clinical Trial Update: Combined Antiinflammatory and Angiostatic Therapy in Patients With Hormone-refractory Prostate Cancer [Phase 2]
Phase 2 trial assessing a combined antiinflammatory and antiangiogenic therapy in patients with hormone-refractory prostate cancer; the stud…
-
CLINICAL_TRIALS trial_result · 2016-10-06Clinical Trial Update: Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer [Phase 2]
A Phase 2 trial evaluated adding the IGF-1R inhibitor cixutumumab to standard androgen deprivation therapy with or without bicalutamide in n…
-
CLINICAL_TRIALS research · 2016-10-05Clinical Trial Update: Hyaluronic Acid for Hypofractionated Prostate Radiotherapy [Phase 2]
Phase 2 clinical trial evaluating hyaluronic acid as an adjunct in hypofractionated radiotherapy for prostate cancer.
-
CLINICAL_TRIALS trial_result · 2016-10-04Clinical Trial Update: Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating an NY-ESO-1 vaccine therapy with or without sirolimus in patients whose tumors express NY-ESO-1.
-
CLINICAL_TRIALS trial_result · 2016-09-27Clinical Trial Update: Hypofractionated Intensity Modulated Radiation Therapy Plus Hormonal Therapy in Patients With High Risk Prostate Cancer [NA]
This clinical trial evaluating hypofractionated intensity-modulated radiation therapy plus hormonal therapy in high-risk prostate cancer has…
-
CLINICAL_TRIALS trial_result · 2016-09-22Clinical Trial Update: Trial to Evaluate Radiotherapy Followed by Endocrine Therapy Vs Endocrine Therapy Alone for PSA Failure After Radical Prostatectomy [Phase 3]
Phase 3 trial evaluating whether radiotherapy followed by endocrine therapy improves outcomes compared with endocrine therapy alone for PSA …
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: A Study Evaluating Vaccination of Prostate Cancer Patients With Self Dendritic Cells Expressing MUC1 [Phase 1, Phase 2]
Phase 1/Phase 2 trial evaluating an autologous dendritic cell vaccine expressing the MUC1 antigen in prostate cancer; the study status is co…
-
CLINICAL_TRIALS research · 2016-09-13Clinical Trial Update: Prospective RCT on Post Prostatectomy Urine Leak [Phase 3]
Phase 3 randomized trial update evaluating treatment for post-prostatectomy urine leakage in men with prostate cancer and urinary incontinen…
-
CLINICAL_TRIALS research · 2016-09-13Clinical Trial Update: Medical and Economic Evaluation for Intermediate-risk Prostate Cancer [NA]
This document provides an update on a clinical trial evaluating medical and economic aspects for intermediate-risk prostate cancer; phase in…
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: Energy Balance for Prostate Cancer Survivorship [NA]
A completed clinical trial update on energy balance for prostate cancer survivorship led by Jill Hamilton-Reeves, PhD RD LD.
-
CLINICAL_TRIALS trial_result · 2016-09-02Clinical Trial Update: Evaluation of a Transrectal Scintigraphic Detector(ProxiScanTM) for Detection of Primary Prostate Cancer [Phase 1]
Phase 1 trial evaluating the ProxiScan transrectal scintigraphic detector for detection of primary prostate cancer. The study status is COMP…
-
CLINICAL_TRIALS research · 2016-09-02Clinical Trial Update: Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer [Phase 3]
Phase 3 clinical trial update evaluating radiation therapy with or without bicalutamide and goserelin in patients with prostate cancer; the …
-
CLINICAL_TRIALS withdrawal · 2016-08-31Clinical Trial Update: Carbon-11 Acetate and Fluorine F 18 Sodium Fluoride PET as a Biomarker of Treatment Response in Patients With Hormone Resistant Metastatic Prostate Cancer [NA]
The clinical trial using PET tracers carbon-11 acetate and fluorine-18 sodium fluoride to assess treatment response in hormone-resistant met…